The Treatment of Patients with Stage IIIA Non-Small Cell Lung Cancer From N2 Disease: Who Returns to the Surgical Arena and Who Survives

Annals of Thoracic Surgery

Volumn 86, Issue 3, 2008, Pages 912-920

  Cerfolio, Robert J ^a   Maniscalco, Lee ^a   Bryant, Ayesha S ^a  

^a Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORACOTOMY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 49549087559     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.04.073     Document Type: Article

References (17)

1. National Cancer Institute. Surveillance, epidemiology and end results (SEER) data. http://seer.cancer.gov/ Accessed Jun 5, 2008
2. Jaklitsch M.T., Herndon II J.E., DeCamp Jr. M.M., et al. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. J Surg Oncol 94 (2006) 599-606
3. Takeda S., Hajime M., Okada T., et al. Results of pulmonary resection following neo-adjuvant therpy for locally advanced (IIIA-IIIB) lung cancer. Eur J Cardiothor Surg 30 (2006) 184-189
4. Mountain C.F. Revisions in the International System; s for Staging Lung Cancer. Chest 111 (1997) 1710-1717
5. Cerfolio R.J., Bryant A.S., Ojha B., et al. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 130 (2005) 151-159
6. Hawes R.H., Gress F., Kesler K.A., Cummings O.W., and Conces Jr. D.J. Endoscopic ultrasound versus computed tomography in the evaluation of the mediastinum in patients with non-small-cell lung cancer. Endoscopy 26 (1994) 784-787
7. Eloubeidi M.A., Cerfolio R.J., Chen V.K., et al. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph nodes in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann Thor Surg 79 (2005) 263-268
8. International Union Against Cancer. Lung tumours. In: Sobin L., and Wittekind C. (Eds). TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York, NY
9. Cerfolio R.J., Bryant A.S., Spencer S.A., et al. Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg 80 (2005) 1224-1230
10. Alberts W.M., and American College of Chest Physicians. Diagnosis and management of lung cancer executive summary. Chest 132 (2007) 1S-19S
11. Riquet M., Bagan P., Barthes F.P., et al. Completely resected non-small cell lung cancer: Reconsidering prognostic value and significance of N2 metastases. Ann Thorac Surg 84 (2007) 1818-1824
12. Garrido P., Gonzalez-Larriba J.L., Insa A., et al. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non-small cell lung cancer patients: The Spanish lung cancer group trial 9901. J Clin Oncol 25 (2007) 4736-4742
13. Sonett J.R., Suntharalingam M., Edelman M.J., et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small cell lung cancer. Ann Thorac Surg 78 (2004) 1200-1206
14. Cerfolio R.J., Bryant A.S., and Yamamuro M. Intercostal muscle flap to buttress the bronchus at risk and the thoracic esophageal gastric anastomosis. Ann Thorac Surg 80 (2005) 1017-1020
15. Cerfolio R.J., Bryant A.S., Ojha B., and Eloubeidi M. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg 80 (2005) 1207-1213
16. Barlesi F., Doddoli C., Chetaille B., et al. Survival and postoperative complication in daily practice after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2 (2003) 558-562
17. Lorent N., De Leyn P., Lievens Y., et al. Long-term survival of surgically staged IIIA-N2 non-small cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol 15 (2004) 1645-1653